ISSN: 2215-0366

Journal Home

Journal Guideline

The Lancet Psychiatry Q1 Unclaimed

Elsevier Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Psychiatry is a journal indexed in SJR in Psychiatry and Mental Health and Biological Psychiatry with an H index of 127. It has an SJR impact factor of 8,167 and it has a best quartile of Q1. It has an SJR impact factor of 8,167.

The Lancet Psychiatry focuses its scope in these topics and keywords: depression, health, mental, symptoms, randomised, thinking, depressive, perinatal, controlled, disabilities, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biological Psychiatry (Q1) Psychiatry and Mental Health (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

8,167

SJR Impact factor

127

H Index

255

Total Docs (Last Year)

941

Total Docs (3 years)

4591

Total Refs

11027

Total Cites (3 years)

317

Citable Docs (3 years)

14.05

Cites/Doc (2 years)

18

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Clinical Psychology Q1
JAMA Psychiatry Q1
Evidence-Based Mental Health Q1
Psychotherapy and Psychosomatics Q1
Clinical Psychology Review Q1

Compare this journals

Aims and Scope

Best articles by citations

My immortal Holmes

Paternal perinatal depression in LMICs and its impact on the next generation

Control of fentanyl-related substances in China

Suicidal behaviour: identifying the best preventive interventions

Infant autism: parents' role in ameliorating risk?

Reification of the paediatric bipolar hypothesis in the USA

Tears of Ishtar: women's mental health in Iraq

What about treatment of smoking to improve survival and reduce depression?

What about treatment of smoking to improve survival and reduce depression? -Authors' reply

The loss of mourning

The Future of Psychiatry Commission

Variations in patterns of involuntary hospitalisation and in legal frameworks: an international comparative study

SHOW MORE ARTICLES

Esketamine as a treatment for paediatric depression: questions of safety and efficacy

The state of mental health care in Pakistan

Screening psychiatrists: the good, the bad, and the dippy

No sex please: we're scientists

New Mental Health Act in Bangladesh -Authors' reply

Turn on and tune in to evidence-based psychedelic research

The family way

The past is present: Last Year at Marienbad

Trans* health: "diversity, not pathology"

Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes

Fool's gold

Mental distress and potentially modifiable social factors in post-conflict Sri Lanka - authors' response